Prosecution Insights
Last updated: April 19, 2026

Tme Therapeutics LLC

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18249728 NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME NOLAN, JASON MICHAEL 1623 Final Rejection Apr 19, 2023
18299657 NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME CHANDRAKUMAR, NIZAL S 1625 Non-Final OA Apr 12, 2023

Managing Tme Therapeutics LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month